COO - יחס שווי שוק לרווח וקצב צמיחה CooperSurgical

Asset diversification between ophthalmology and women's health ensures capital stability for The Cooper Companies (COO). The P/E to growth rate dynamics visualize this efficiency, where the 1.91 indicator determines the metric's magnitude. While an oligopolistic market demands constant innovation to maintain market share, the demand for daily disposable lenses guarantees a steady cash flow and high operating profit.

The seamless integration of external suppliers allows The Cooper Companies (COO) to rapidly scale lens production, directly impacting profit dynamics. An analysis of the growth-normalized P/E, which compares the market multiple to business expansion rates, reveals the asset is undervalued when the value is below one, helping investors distinguish fundamental growth potential from a temporary decline in share prices.